CBD May Reduce Orofacial Pain, Study Suggests

Chronic pain rarely exists in isolation. For many people suffering from orofacial inflammatory pain, pain affecting the mouth, jaw, lips, or face, the physical discomfort is often accompanied by anxiety, depression, and cognitive difficulties. These overlapping symptoms can significantly reduce quality of life, yet many conventional pain medications fail to address the full scope of the problem.

A new 2026 study¹ published in Brain Research Bulletin explores a promising alternative: cannabidiol (CBD). The non-human research suggests that CBD may help relieve both the physical sensations of inflammatory pain and the emotional distress associated with it. Even more compelling, the study sheds light on how CBD works in the body, revealing mechanisms involving the endocannabinoid system, inflammation pathways, and serotonin signaling in the brain.

The findings highlight CBD’s potential as a multi-dimensional treatment strategy for inflammatory pain conditions, especially those affecting the face and jaw. Let’s explore this groundbreaking finding.

Understanding Orofacial Inflammatory Pain

Orofacial pain refers to discomfort originating in the mouth, teeth, jaw, face, or related nerves. It can arise from numerous conditions, including dental inflammation, temporomandibular joint disorders (TMJ), nerve injury, and infections. Because the face contains a dense network of nerves, pain in this region can be particularly intense and persistent.

Inflammatory forms of orofacial pain often involve heightened nerve sensitivity and ongoing immune activity, which makes treatment challenging. Standard therapies, such as NSAIDs, opioids, or corticosteroids, may provide partial relief but often fail to address the neurological and emotional dimensions of chronic pain.

Researchers increasingly recognize that chronic pain can trigger changes in mood, stress response, and cognitive function, creating a feedback loop that worsens the overall experience of pain. This is why scientists are investigating treatments that target both sensory pain signals and emotional processing in the brain.

CBD may be uniquely suited to this role.

How Scientists Studied CBD and Orofacial Pain

To explore CBD’s therapeutic potential, scientists used established mouse models of acute and chronic inflammatory pain.

In the first phase of the study, researchers induced acute orofacial pain by injecting formalin into the upper lip of mice. This method produces a predictable inflammatory pain response that occurs in two phases: an immediate pain reaction followed by a longer inflammatory sensitization phase.

To model chronic inflammatory pain, researchers used injections of complete Freund’s adjuvant (CFA) in the paws of mice. This method triggers prolonged inflammation and pain hypersensitivity, mimicking aspects of chronic inflammatory conditions.

The study also included a comprehensive set of behavioral tests to measure not just pain responses, but also emotional and cognitive changes associated with chronic pain. These assessments included:

• Mechanical sensitivity testing to measure pain thresholds
• Anxiety-related behavior tests
• Depression-like behavioral evaluations
• Cognitive function tests related to memory and exploration

Additionally, the researchers used advanced laboratory techniques, including molecular analysis and brain imaging tools, to investigate how CBD affected inflammatory pathways, endocannabinoid signaling, and neurotransmitter activity.

Swipe to scroll →

CBD Reduced Orofacial Inflammatory Pain

One of the most immediate findings was that locally administered CBD significantly reduced acute inflammatory pain in the facial region.

When CBD was applied near the site of inflammation, it suppressed the second phase of formalin-induced pain. This is the stage associated with inflammatory sensitization and prolonged discomfort. This suggests CBD may be particularly effective at targeting inflammation-driven pain signals rather than simply masking symptoms.

At the biological level, the researchers found several key changes.

CBD decreased levels of pro-inflammatory cytokines, including IL-1β and TNF-α, both of which play major roles in inflammatory pain pathways. It also reduced levels of prostaglandin E2 (PGE2), a compound known to amplify pain signals during inflammation.

Another important finding involved the enzyme FAAH, which normally breaks down endocannabinoids in the body. CBD suppressed this enzyme, allowing levels of natural endocannabinoids to increase.

These effects were largely mediated through activation of CB2 receptors, which are part of the body’s endocannabinoid system and are closely associated with immune regulation and inflammation.

CBD Influences Pain Processing in the Brain

While CBD’s anti-inflammatory effects helped reduce pain at the peripheral level, the study also revealed important changes within the central nervous system.

Researchers observed reduced neuronal activity in key brain regions involved in pain perception, including the spinal trigeminal nucleus caudalis and the anterior cingulate cortex. These areas play critical roles in transmitting and interpreting pain signals from the face and jaw.

CBD also increased levels of anandamide (AEA), often referred to as the body’s “bliss molecule,” in several brain regions associated with pain modulation, including the periaqueductal gray.

Unlike the peripheral anti-inflammatory effects, these central nervous system changes were primarily linked to CB1 receptor signaling, another component of the endocannabinoid system.

Together, these findings suggest that CBD can influence multiple layers of pain processing, from immune responses at the site of inflammation to neurological circuits that interpret pain in the brain.

CBD Reduced Anxiety and Depression in Pain Models

Chronic pain does not just affect the body; it also impacts mental health. People living with long-term pain often experience anxiety, depression, and difficulties with concentration or memory. In the chronic pain model used in the study, mice developed behavioral patterns that resemble these emotional and cognitive symptoms.

Systemic administration of CBD produced striking improvements. Animals receiving CBD showed reduced anxiety-like and depression-like behaviors, as well as improved performance in cognitive tests designed to evaluate memory and exploratory behavior.

These improvements suggest that CBD may help address pain-related emotional and cognitive impairments, not just physical pain itself.

CBD Restored Serotonin Signaling

A particularly intriguing discovery involved the neurotransmitter serotonin, which plays a major role in regulating mood, stress, and emotional resilience.

Researchers observed that chronic pain disrupted serotonin signaling in the central amygdala, a brain region heavily involved in emotional processing and fear responses. Using advanced imaging techniques, the scientists found that CBD restored normal serotonin activity in this region.

This finding may help explain why CBD improved anxiety and depression-like symptoms in the study. By stabilizing serotonin signaling in emotional centers of the brain, CBD may help break the cycle between chronic pain and negative emotional states.

Why These Findings Matter

Although the research was conducted in animal models, the results provide important insights into how CBD may work in humans experiencing inflammatory pain conditions.

Unlike many conventional pain medications, CBD appears to target multiple biological systems simultaneously, including:

• Inflammatory pathways
• The endocannabinoid system
• Pain-processing neural circuits
• Serotonin signaling related to mood

This multi-target approach could be especially valuable for conditions where pain, stress, and emotional health are deeply interconnected. Orofacial pain conditions can be particularly difficult to treat because they involve complex sensory and emotional components. Therapies capable of addressing both aspects may provide more comprehensive relief.

The Future of CBD in Pain Management

The authors of the study conclude that CBD demonstrates strong therapeutic potential across sensory, emotional, and cognitive dimensions of inflammatory pain.

Future research will be needed to determine optimal dosing, delivery methods, and safety in human patients. Clinical trials will ultimately be necessary to confirm whether the same mechanisms observed in animal models apply to people.

However, the findings contribute to a growing body of evidence suggesting that CBD may serve as a novel strategy for managing complex pain conditions. As scientific understanding of the endocannabinoid system and pain biology continues to expand, cannabinoids like CBD may play an increasingly important role in the next generation of pain therapies.

For individuals living with chronic orofacial pain, that possibility offers a hopeful glimpse into the future of more holistic and effective treatment approaches.

References:

^{1. Wuyue W, Guanbo X, Xu B, Jianwei X, Danni C, Xiankui S, Zou W, Wu N, Li J, Han X. Effects and Mechanisms of Cannabidiol in Attenuating Orofacial Inflammatory Pain and Ameliorating Pain-Related Affective Deficits. Brain Res Bull. 2026 Mar 6:111813. doi: 10.1016/j.brainresbull.2026.111813. Epub ahead of print. PMID: 41796907. Effects and Mechanisms of Cannabidiol in Attenuating Orofacial Inflammatory Pain and Ameliorating Pain-Related Affective Deficits – PubMed}